NIMC
BIO icon

NWQ Investment Management Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

NWQ Investment Management Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$31.8M Sell
61,779
-8,688
-12% -$4.4M 1.44% 14
2020
Q2 		$31.8K Sell
70,467
-34,728
-33% -$15.3M 1.06% 18
2020
Q1 		$36.9M Sell
105,195
-22,091
-17% -$8.12M 1.48% 12
2019
Q4 		$47.1M Sell
127,286
-20,380
-14% -$7.18M 1.17% 25
2019
Q3 		$49.1M Sell
147,666
-7,361
-5% -$2.4M 1.19% 23
2019
Q2 		$48.5M Sell
155,027
-4,064
-3% -$1.22M 1.09% 25
2019
Q1 		$48.6M Buy
159,091
+17,928
+13% +$4.84M 1.06% 28
2018
Q4 		$32.8M Sell
141,163
-9,528
-6% -$2.56M 0.78% 57
2018
Q3 		$47.2M Sell
150,691
-23,069
-13% -$7.16M 0.93% 38
2018
Q2 		$50.1M Sell
173,760
-42,270
-20% -$11.7M 0.9% 39
2018
Q1 		$53.5M Sell
216,030
-41,053
-16% -$10.5M 0.86% 44
2017
Q4 		$61.4M Sell
257,083
-30,493
-11% -$7.39M 0.8% 37
2017
Q3 		$63.9M Sell
287,576
-25,539
-8% -$5.75M 0.78% 36
2017
Q2 		$70.9M Sell
313,115
-11,165
-3% -$2.43M 0.98% 34
2017
Q1 		$65.6M Sell
324,280
-81,877
-20% -$15.8M 0.86% 43
2016
Q4 		$74M Sell
406,157
-64,420
-14% -$11M 1.01% 26
2016
Q3 		$77.1M Sell
470,577
-32,889
-7% -$4.99M 1.12% 25
2016
Q2 		$72M Buy
503,466
+80,920
+19% +$11.5M 1.24% 26
2016
Q1 		$57.8M Sell
422,546
-3,330
-0.8% -$437K 0.9% 47
2015
Q4 		$59.1M Sell
425,876
-17,729
-4% -$2.46M 0.91% 46
2015
Q3 		$59.6M Sell
443,605
-53,941
-11% -$7.76M 0.92% 47
2015
Q2 		$74.3M Sell
497,546
-24,301
-5% -$3.48M 1.03% 38
2015
Q1 		$70.5M Sell
521,847
-36,531
-7% -$4.53M 0.88% 51
2014
Q4 		$67.3M Buy
558,378
+32,272
+6% +$3.71M 0.81% 51
2014
Q3 		$59.3M Buy
526,106
+2,300
+0.4% +$273K 0.65% 49
2014
Q2 		$62.7M Buy
523,806
+89,907
+21% +$11M 0.63% 50
2014
Q1 		$55.6M Buy
433,899
+102,088
+31% +$13.1M 0.49% 54
2013
Q4 		$41M Buy
331,811
+309,338
+1,376% +$37.7M 0.36% 59
2013
Q3 		$2.64M Buy
+22,473
New +$2.65M 0.03% 130

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NWQ Investment Management Company's BIO Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Bio-Rad Laboratories Class A (BIO) stake by 12% in Q3 2020, selling an estimated $4.4M and leaving 61,779 shares worth $31.8M. The position accounts for 1.44% of the portfolio, ranked #14.

NWQ Investment Management Company first reported a position in BIO in Q3 2013 and has held it in 29 quarters since. The position peaked at $77.1M in Q3 2016. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • NWQ Investment Management Company held 61,779 shares of Bio-Rad Laboratories Class A worth $31.8M as of Q3 2020.
  • NWQ Investment Management Company sold 8,688 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $4.4M.
  • Bio-Rad Laboratories Class A made up 1.44% of NWQ Investment Management Company's portfolio in Q3 2020, its #14 holding.
  • NWQ Investment Management Company first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and has held it in 29 quarters since.
  • NWQ Investment Management Company's Bio-Rad Laboratories Class A position peaked at $77.1M in Q3 2016.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.